Universität zu Köln

Welz, Tanya, Wyen, Christoph and Hensel, Manfred (2017). Drug Interactions in the Treatment of Malignancy in HIV-Infected Patients. Oncol. Res. Treat., 40 (3). S. 120 - 127. BASEL: KARGER. ISSN 2296-5262

Full text not available from this repository.

Abstract

The number of patients with HIV (human immunodeficiency virus) requiring treatment for malignancy is increasing worldwide. Concurrent treatment of HIV and malignancy is complicated by unpredictable drug-drug interactions, which can cause potentially life-threatening toxicities and ineffective treatment of either disease. This article aims to provide a practical approach to drug interactions and their management in this context to help deliver effective and safe treatment of both the malignancy and HIV. (C) 2017 S. Karger GmbH, Freiburg

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Welz, Tanya UNSPECIFIED UNSPECIFIED UNSPECIFIED Wyen, Christoph UNSPECIFIED UNSPECIFIED UNSPECIFIED Hensel, Manfred UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-238310
DOI:	10.1159/000458443
Journal or Publication Title:	Oncol. Res. Treat.
Volume:	40
Number:	3
Page Range:	S. 120 - 127
Date:	2017
Publisher:	KARGER
Place of Publication:	BASEL
ISSN:	2296-5262
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; STEM-CELL TRANSPLANTATION; NON-HODGKIN-LYMPHOMA; ANTICANCER DRUGS; PHARMACOKINETIC INTERACTION; TENOFOVIR ALAFENAMIDE; HUMAN HEPATOCYTES; POSITIVE PATIENTS; KAPOSIS-SARCOMA Multiple languages Oncology Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/23831